Traws Pharma
TRAW
TRAW
24 hedge funds and large institutions have $1.04M invested in Traws Pharma in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Holders
24
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$20.7K | |
| 2 | +$4K | |
| 3 | +$734 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$91 |
Top Sellers
| 1 | -$20K | |
| 2 | -$19.2K | |
| 3 | -$17.1K | |
| 4 |
Renaissance Technologies
New York
|
-$16.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$12K |